Your browser doesn't support javascript.
loading
CEUS and CT/MRI LI-RADS in Association With Serum Biomarkers for Differentiation of Combined Hepatocellular-Cholangiocarcinoma From Hepatocellular Carcinoma.
Zhou, Yan; Yin, Shanshan; Zhao, Lin; Zhang, Xiang; Li, Meng; Ding, Jianmin; Yan, Kun; Jing, Xiang.
Afiliación
  • Zhou Y; School of Medicine, Nankai University, Tianjin, China.
  • Yin S; Department of Ultrasound, Tianjin Third Central Hospital, Tianjin, China.
  • Zhao L; Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Third Central Hospital, Tianjin, China.
  • Zhang X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Ultrasound, Peking University Cancer Hospital and Institute, Beijing, China.
  • Li M; Department of Ultrasound, Tianjin Third Central Hospital, Tianjin, China.
  • Ding J; Tianjin Institute of Hepatobiliary Disease, Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Artificial Cell Engineering Technology Research Center, Tianjin Third Central Hospital, Tianjin, China.
  • Yan K; Department of Radiology, Tianjin Third Central Hospital, Tianjin, China.
  • Jing X; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Ultrasound, Peking University Cancer Hospital and Institute, Beijing, China.
Front Oncol ; 12: 897090, 2022.
Article en En | MEDLINE | ID: mdl-35651804
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza